Bio-Path Holdings Inc.

08/21/2024 | Press release | Distributed by Public on 08/21/2024 05:29

Bio Path Holdings Reports Solid Tumor Patient Response Supporting BP1001 A’s Compelling Potential as Treatment for Advanced Solid Tumors